tiprankstipranks
Trending News
More News >
Rekah Pharmaceutical Industry Ltd. (IL:REKA)
:REKA
Israel Market

Rekah (REKA) Income Statement

Compare
0 Followers

Rekah Income Statement

Last quarter (Q4 2024), Rekah's total revenue was 76.16M, a decrease of -11.49% from the same quarter last year. In Q4, Rekah's net income was -2.32M. See Rekah’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
321.71M 321.66M 292.39M 263.95M 265.47M
Gross Profit
71.95M 80.20M 78.70M 65.16M 68.64M
Operating Expenses
55.58M 79.67M 63.54M 51.47M 46.82M
Depreciation and Amortization
32.66M 23.12M 27.48M 22.86M 19.71M
EBITDA
47.30M 26.03M 40.24M 36.20M 39.68M
Operating Income
16.37M 2.91M 13.25M 14.14M 20.92M
Other Income/Expenses
-8.44M -9.96M -12.90M -5.20M -6.76M
Pretax Income
7.93M -7.05M 357.00K 7.71M 14.16M
Net Income
6.21M -6.91M -2.04M 6.62M 10.80M
Per Share Metrics
Basic EPS
0.52 -0.61 -0.18 0.58 0.95
Diluted EPS
0.52 -0.61 -0.18 0.58 0.95
Weighted Average Shares Outstanding
11.98M 11.33M 11.34M 11.41M 11.41M
Weighted Average Shares Outstanding (Diluted)
11.98M 11.41M 11.41M 11.41M 11.41M
Currency in ILS

Rekah Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis